This page shows Textron (TXT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Textron’s recent per-share progress is being driven by steady cash generation and buybacks more than higher absolute profit.
The less obvious pattern is financial engineering supported by real cash flow, not a step-change in operating earnings. Net income was back to$921M , and buybacks still absorbed$822M of free cash flow, so per-share improvement reflects capital return as much as larger enterprise earnings.
Cash conversion remains healthy: operating cash flow reached
The weaker spot is working-capital drag. Inventory rose to
Financial Health Signals
Based on FY2026 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Textron's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Textron's revenue grew 8.0% year-over-year to $14.8B, a solid pace of expansion. This earns a growth score of 40/100.
Textron carries a low D/E ratio of 1.27, meaning only $1.27 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 76/100, indicating a strong balance sheet with room for future borrowing.
Textron has a free cash flow margin of 6.3%, earning a moderate score of 40/100. The company generates positive cash flow after capital investments, but with room for improvement.
Textron's ROE of 11.5% shows moderate profitability relative to equity, earning a score of 37/100. This is up from 11.4% the prior year.
Textron passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Textron generates $1.42 in operating cash flow ($1.3B OCF vs $921.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Textron generated $14.8B in revenue in fiscal year 2026. This represents an increase of 8.0% from the prior year.
Textron reported $921.0M in net income in fiscal year 2026. This represents an increase of 11.8% from the prior year.
Textron earned $5.11 per diluted share (EPS) in fiscal year 2026. This represents an increase of 18.0% from the prior year.
Cash & Balance Sheet
Textron generated $929.0M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 42.9% from the prior year.
Textron held $1.6B in cash against $0 in long-term debt as of fiscal year 2026.
Textron paid $0.08 per share in dividends in fiscal year 2026. This represents an increase of 0.0% from the prior year.
Textron had 174M shares outstanding in fiscal year 2026. This represents a decrease of 4.8% from the prior year.
Margins & Returns
Textron's net profit margin was 6.2% in fiscal year 2026, showing the share of revenue converted to profit. This is up 0.2 percentage points from the prior year.
Textron's ROE was 11.5% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 0.1 percentage points from the prior year.
Capital Allocation
Textron invested $521.0M in research and development in fiscal year 2026. This represents an increase of 6.1% from the prior year.
Textron spent $822.0M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 26.7% from the prior year.
Textron invested $383.0M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 5.2% from the prior year.
TXT Income Statement
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.7B-11.5% | $4.2B+15.9% | $3.6B-3.1% | $3.7B+12.4% | $3.3B-8.5% | $3.6B+5.4% | $3.4B-2.8% | $3.5B |
| Cost of Revenue | $2.6B | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $533.0M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $120.0M-10.4% | $134.0M+13.6% | $118.0M-13.9% | $137.0M+3.8% | $132.0M+13.8% | $116.0M-7.9% | $126.0M+20.0% | $105.0M |
| SG&A Expenses | $321.0M+1.9% | $315.0M+22.6% | $257.0M-15.2% | $303.0M+1.7% | $298.0M+12.5% | $265.0M-6.0% | $282.0M-3.8% | $293.0M |
| Operating Income | $154.0M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | -$34.0M+5.6% | -$36.0M-20.0% | -$30.0M+3.2% | -$31.0M-6.9% | -$29.0M-11.5% | -$26.0M0.0% | -$26.0M-4.0% | -$25.0M |
| Income Tax | $47.0M+9.3% | $43.0M-46.9% | $81.0M+44.6% | $56.0M+64.7% | $34.0M+440.0% | -$10.0M-134.5% | $29.0M-54.0% | $63.0M |
| Net Income | $220.0M-6.4% | $235.0M+0.4% | $234.0M-4.5% | $245.0M+18.4% | $207.0M+46.8% | $141.0M-36.8% | $223.0M-13.9% | $259.0M |
| EPS (Diluted) | $1.25 | N/A | $1.31-3.0% | $1.35+19.5% | $1.13 | N/A | $1.18-12.6% | $1.35 |
TXT Balance Sheet
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.1B+0.1% | $18.1B+4.3% | $17.4B+1.8% | $17.1B+0.8% | $16.9B+0.6% | $16.8B+2.3% | $16.5B+0.2% | $16.4B |
| Current Assets | $8.0B | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $1.6B-20.5% | $2.0B+33.0% | $1.5B+6.1% | $1.4B+15.2% | $1.2B-13.6% | $1.4B+7.0% | $1.3B-4.5% | $1.4B |
| Inventory | $4.6B+6.6% | $4.3B-4.2% | $4.5B+2.9% | $4.3B+1.6% | $4.3B+4.9% | $4.1B-7.7% | $4.4B+0.7% | $4.4B |
| Accounts Receivable | $885.0M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $2.3B | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $10.1B-1.1% | $10.3B+3.7% | $9.9B+2.5% | $9.6B-0.2% | $9.7B+0.3% | $9.6B+1.4% | $9.5B-0.8% | $9.6B |
| Current Liabilities | $4.7B | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $339.0M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $8.0B+1.6% | $7.9B+5.1% | $7.5B+0.8% | $7.4B+2.2% | $7.3B+1.0% | $7.2B+3.6% | $7.0B+1.4% | $6.9B |
| Retained Earnings | $6.0B+3.8% | $5.8B-7.9% | $6.3B+3.8% | $6.1B+4.1% | $5.8B+3.6% | $5.6B-14.2% | $6.5B+3.5% | $6.3B |
TXT Cash Flow Statement
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$117.0M-116.7% | $700.0M+100.6% | $349.0M-9.8% | $387.0M+412.1% | -$124.0M-127.8% | $446.0M+114.4% | $208.0M-43.3% | $367.0M |
| Capital Expenditures | $133.0M-23.1% | $173.0M+127.6% | $76.0M-2.6% | $78.0M+39.3% | $56.0M-63.4% | $153.0M+115.5% | $71.0M-4.1% | $74.0M |
| Free Cash Flow | -$250.0M-147.4% | $527.0M+93.0% | $273.0M-11.7% | $309.0M+271.7% | -$180.0M-161.4% | $293.0M+113.9% | $137.0M-53.2% | $293.0M |
| Investing Cash Flow | -$104.0M+35.8% | -$162.0M-161.3% | -$62.0M-444.4% | $18.0M+1900.0% | -$1.0M+98.9% | -$95.0M-21.8% | -$78.0M-62.5% | -$48.0M |
| Financing Cash Flow | -$193.0M-436.1% | -$36.0M+81.7% | -$197.0M+15.1% | -$232.0M-197.4% | -$78.0M+67.5% | -$240.0M-17.1% | -$205.0M+44.9% | -$372.0M |
| Dividends Paid | $3.0M-57.1% | $7.0M+75.0% | $4.0M0.0% | $4.0M+33.3% | $3.0M-25.0% | $4.0M | $0-100.0% | $4.0M |
| Share Buybacks | $168.0M-10.2% | $187.0M-9.2% | $206.0M-3.7% | $214.0M-0.5% | $215.0M-7.3% | $232.0M+7.9% | $215.0M-39.9% | $358.0M |
TXT Financial Ratios
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 16.9% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 4.9% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 5.9%+0.3pp | 5.6%-0.9pp | 6.5%-0.1pp | 6.6%+0.3pp | 6.3%+2.4pp | 3.9%-2.6pp | 6.5%-0.8pp | 7.3% |
| Return on Equity | 2.8%-0.2pp | 3.0%-0.1pp | 3.1%-0.2pp | 3.3%+0.5pp | 2.9%+0.9pp | 2.0%-1.2pp | 3.2%-0.6pp | 3.8% |
| Return on Assets | 1.2%-0.1pp | 1.3%-0.1pp | 1.4%-0.1pp | 1.4%+0.2pp | 1.2%+0.4pp | 0.8%-0.5pp | 1.4%-0.2pp | 1.6% |
| Current Ratio | 1.70 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 1.27-0.0 | 1.30-0.0 | 1.32+0.0 | 1.30-0.0 | 1.330.0 | 1.34-0.0 | 1.37-0.0 | 1.40 |
| FCF Margin | -6.8%-19.4pp | 12.6%+5.0pp | 7.6%-0.7pp | 8.3%+13.8pp | -5.4%-13.6pp | 8.1%+4.1pp | 4.0%-4.3pp | 8.3% |
Similar Companies
Frequently Asked Questions
What is Textron's annual revenue?
Textron (TXT) reported $14.8B in total revenue for fiscal year 2026. This represents a 8.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Textron's revenue growing?
Textron (TXT) revenue grew by 8% year-over-year, from $13.7B to $14.8B in fiscal year 2026.
Is Textron profitable?
Yes, Textron (TXT) reported a net income of $921.0M in fiscal year 2026, with a net profit margin of 6.2%.
What is Textron's net profit margin?
Textron (TXT) had a net profit margin of 6.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Does Textron pay dividends?
Yes, Textron (TXT) paid $0.08 per share in dividends during fiscal year 2026.
What is Textron's return on equity (ROE)?
Textron (TXT) has a return on equity of 11.5% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Textron's free cash flow?
Textron (TXT) generated $929.0M in free cash flow during fiscal year 2026. This represents a 42.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Textron's operating cash flow?
Textron (TXT) generated $1.3B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Textron's total assets?
Textron (TXT) had $18.1B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Textron's capital expenditures?
Textron (TXT) invested $383.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Textron spend on research and development?
Textron (TXT) invested $521.0M in research and development during fiscal year 2026.
What is Textron's debt-to-equity ratio?
Textron (TXT) had a debt-to-equity ratio of 1.27 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Textron's return on assets (ROA)?
Textron (TXT) had a return on assets of 5.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Textron's Piotroski F-Score?
Textron (TXT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Textron's earnings high quality?
Textron (TXT) has an earnings quality ratio of 1.42x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Textron?
Textron (TXT) scores 32 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.